A MULTI-CENTER, NONRANDOMIZED PHARMACOKINETIC STUDY OF MAKENA (HYDROXYPROGESTERONE CAPROATE INJECTION, 250 MG/ML) AND ITS METABOLITES IN BLOOD AND URINE OF WOMEN WITH A SINGLETON PREGNANCY AND A PREVIOUS SINGLETON SPONTANEOUS PRETERM DELIVERY
Clinical Trial Grant
Administered By
Obstetrics and Gynecology, Maternal Fetal Medicine
Awarded By
KV Pharmaceutical Company
Start Date
September 10, 2013
End Date
September 9, 2014
Administered By
Obstetrics and Gynecology, Maternal Fetal Medicine
Awarded By
KV Pharmaceutical Company
Start Date
September 10, 2013
End Date
September 9, 2014